Optimal timing of radiotherapy following radical prostatectomy
Optimal timing of radiotherapy following radical prostatectomy
Safety and tolerability of AVB500 in platinum-resistant recurrent ovarian cancer
INVICTUS: Assessing the safety and efficacy of ripretinib in patients with advanced gastrointestinal stromal tumours
Using PARP inhibitors to improve quality of life for patients with metastatic breast cancer
Holistic management of patients with ALK-positive NSCLC
Precision medicine in ALK-positive NSCLC: Results from the BFAST trial
Prostate cancer updates: Advances in precision medicine and PARP inhibitors
Health-related quality of life for patients with metastatic pancreatic cancer: Updates from ESMO 2019
Role of molecular diagnostics in prostate cancer
Key developments in pancreatic cancer from ESMO 2019
Breast cancer highlights from ESMO 2019
Melanoma highlights from ESMO 2019